Morepen Laboratories Limited (MOREPENLAB.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
| Market Cap | 18.47B |
| Enterprise Value | 19.86B |
| P/E Ratio | 28.2 |
| PEG Ratio | 0.31 |
| Price/Sales Ratio | 2.32 |
| Price/Book Ratio | 3.84 |
| Enterprise/Revenue | 2.39 |
| Enterprise/EBITDA | 18.39 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.08 |
| Operating Margin | 0.11 |
| Return On Assets | 0.08 |
| Return On Equity | 0.15 |
| Revenue | 18.06B |
| Revenue/Share | 41.68 |
| Gross Profit | 6.82B |
| EBITDA | 1.73B |
| Net Income | 948.77M |
| Diluted EPS | 1.73 |
| Total Cash | 2.84B |
| Total Cash/Share | 5.19 |
| Total Debt | 3.23B |
| Total Debt/Equity | 0.23 |
| Current Ratio | 1.98 |
| Book Value Per Share | 25.2 |
| 52-Week Change | 108.72 |
| 52-Week High | 150.7 |
| 52-Week Low | 33.05 |
| Moving Average 50 Days | 119.38 |
| Moving Average 200 Days | 68.47 |
| Average Volume | 17.21M |
| Shares Outstanding | 547.95M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0.2 |
| Trailing Annual Dividend Yield | 0.21 |
| Payout Ratio | 0.06 |
| Last Split Factor | 5:1 |
| Last Split Date | November 07, 2000 |